V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20206395 | 20127575 | 1.76 | 80.5 | Palliative (P) | 2017-04-11 | 2017-04-11 | Cape+Cisplatin+Trastuzumab Load | 99 | Y | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101495600 |
| 20206397 | 20127576 | 1.56 | 52.5 | Palliative (P) | 2017-07-07 | 2017-07-26 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100988148 |
| 20206401 | 20127577 | 1.77 | 57 | Neo-adjuvant (N) | 2020-02-15 | 2020-02-15 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 101058380 |
| 20206406 | 20127578 | 1.7 | 97 | null | 2018-06-27 | 2018-07-08 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101007867 |
| 20206414 | 20127579 | 1.7 | 72.2 | Palliative (P) | 2021-03-22 | 2021-04-29 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100656874 |
| 20206418 | 20127580 | 1.7 | 63.6 | Palliative (P) | 2021-09-02 | 2021-09-03 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101774532 |
| 20206435 | 20127581 | null | 84.2 | Adjuvant (A) | 2019-05-14 | 2019-05-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101802963 |
| 20206436 | 20127582 | 1.6 | 90 | null | 2017-05-25 | 2017-05-25 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101065245 |
| 20206439 | 20127583 | 1.74 | 72.7 | Palliative (P) | 2016-12-06 | 2018-04-26 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101366235 |
| 20206441 | 20127584 | 1.7 | 89 | Curative (C) | 2018-12-29 | 2019-01-11 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100545680 |
| 20206443 | 20127585 | 1.82 | 69.9 | null | 2018-02-12 | 2018-02-22 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101450822 |
| 20206445 | 20127586 | 1.74 | 85.8 | null | 2019-01-30 | 2019-02-27 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | N | null | GEMCITABINE + NAB-PACLITAXEL | 100569326 |
| 20206446 | 20127587 | 1.74 | 63 | Palliative (P) | 2017-10-31 | 2017-11-05 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CARBOPLATIN | 100115984 |
| 20206453 | 20127588 | 1.87 | 59.7 | Palliative (P) | 2016-08-01 | 2016-08-15 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101592799 |
| 20206458 | 20127589 | 1.59 | 66.1 | null | 2017-02-07 | 2017-03-21 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 101697266 |
| 20206461 | 20127590 | 1.8 | 60 | Palliative (P) | 2017-08-17 | 2017-09-14 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101265540 |
| 20206467 | 20127591 | 1.83 | 103.5 | null | 2017-12-22 | 2017-12-26 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101362103 |
| 20206478 | 20127592 | 1.55 | 94.3 | Palliative (P) | 2016-08-06 | 2016-08-20 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101676788 |
| 20206480 | 20127593 | 1.63 | 57.2 | null | 2017-04-14 | 2017-04-16 | ECX | 99 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100364677 |
| 20206485 | 20127594 | 1.54 | 60 | Palliative (P) | 2018-02-15 | 2018-02-15 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101239876 |
| 20206489 | 20127595 | 1.8 | 62.8 | Adjuvant (A) | 2021-02-17 | 2021-03-03 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100574255 |
| 20206493 | 20127596 | 1.87 | 79 | Palliative (P) | 2016-09-17 | 2016-10-14 | HCX (Cape + Cisp + Tras) - Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101303715 |
| 20206496 | 20127597 | 1.65 | 57.2 | Adjuvant (A) | 2016-12-17 | 2017-04-23 | Cape+Cisplatin+Trastuzumab Main | 2 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101406388 |
| 20206500 | 20127598 | 1.5 | 70.95 | Palliative (P) | 2019-12-12 | 2019-12-22 | HCX | null | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101347814 |
| 20206502 | 20127599 | 1.8 | 38.9 | null | 2018-11-03 | 2019-04-23 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101638305 |
| 20206504 | 20127600 | 1.79 | 83.7 | Palliative (P) | 2019-07-01 | 2020-08-08 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100382091 |
| 20206506 | 20127601 | 1.56 | 48.8 | null | 2019-05-14 | 2019-06-04 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 01 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101461645 |
| 20206507 | 20127602 | 1.68 | 54 | Palliative (P) | 2017-09-02 | 2017-10-27 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 101620051 |
| 20206508 | 20127603 | 1.72 | 77.6 | Palliative (P) | 2021-01-09 | 2021-02-05 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100237006 |
| 20206509 | 20127604 | 1.6 | 59.5 | null | 2016-09-06 | 2016-12-06 | ECX | 01 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100394305 |
| 20206520 | 20127605 | 1.59 | 58 | null | 2019-07-09 | 2019-11-14 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100920775 |
| 20206522 | 20127606 | 1.75 | 72.8 | Palliative (P) | 2017-03-25 | 2017-04-04 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100353126 |
| 20206525 | 20127607 | 1.71 | 83 | Curative (C) | 2018-05-13 | 2018-05-16 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101529797 |
| 20206526 | 20127608 | 1.54 | 80.8 | Palliative (P) | 2022-01-09 | 2022-01-16 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100822113 |
| 20206533 | 20127609 | 1.8 | 93.4 | null | 2018-11-09 | 2018-12-14 | Cape+Cisplatin+Trastuzumab Load | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101199793 |
| 20206534 | 20127610 | 1.83 | 78 | Palliative (P) | 2017-10-28 | 2017-11-09 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101278719 |
| 20206535 | 20127611 | 1.62 | 114 | null | 2017-03-15 | 2017-06-13 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100403091 |
| 20206536 | 20127612 | 1.74 | 74 | Palliative (P) | 2018-03-31 | 2018-06-10 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100219156 |
| 20206537 | 20127613 | 1.77 | 59.8 | Palliative (P) | 2020-08-30 | 2020-10-10 | GEMCITABINE + NAB PACLITAXEL | null | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101398331 |
| 20206542 | 20127614 | 1.7 | 81.9 | Curative (C) | 2019-04-26 | 2019-05-03 | HCX (Cape + Cisp + Tras) - Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100734832 |
| 20206546 | 20127615 | 1.71 | 88 | Palliative (P) | 2016-02-28 | 2016-03-12 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100757014 |
| 20206567 | 20127616 | 1.52 | 151 | Adjuvant (A) | 2015-02-17 | 2018-02-21 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101021247 |
| 20206573 | 20127617 | 1.6 | 42.5 | null | 2020-02-25 | 2020-04-14 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100880042 |
| 20206576 | 20127618 | 1.71 | 55 | Palliative (P) | 2018-03-28 | 2018-04-11 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100493509 |
| 20206577 | 20127619 | 1.76 | 54.6 | null | 2017-04-07 | 2018-02-19 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101007628 |
| 20206579 | 20127620 | 1.62 | 53.5 | Curative (C) | 2016-09-16 | 2016-10-14 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100506023 |
| 20206580 | 20127621 | 1.81 | 62 | Palliative (P) | 2019-08-28 | 2019-09-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100001396 |
| 20206589 | 20127622 | 1.62 | 58 | Adjuvant (A) | 2020-06-23 | 2020-07-08 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101466117 |
| 20206590 | 20127623 | 1.83 | 42 | Palliative (P) | 2017-04-20 | 2017-09-23 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100303084 |
| 20206606 | 20127624 | 1.81 | 69 | null | 2017-11-17 | 2017-11-23 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100308266 |